Onward Medical using 2 grants to test spinal stimulation device
Onward Medical has received two grants totaling about $2.5 million to support early feasibility studies assessing whether its implantable…
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Onward Medical has received two grants totaling about $2.5 million to support early feasibility studies assessing whether its implantable…
A research advocate diagnosed with Parkinson’s disease and a former nurse with Alzheimer’s disease were among recipients of volunteer…
Moving Day, a signature fundraiser for the Parkinson’s Foundation, will join communities this spring to raise awareness and money…
Six months of treatment with intranasal FGF-1, a naturally occurring molecule that promotes blood vessel growth, improved blood flow in…
Sexual health among women with Parkinson’s disease is associated with sleep quality and the quality of the relationships they…
Estrogen, a female sex hormone, was found to enhance the neuroprotective effects of cytisine, a smoking cessation drug, in a…
A grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) will allow Australia-based Kazia Therapeutics to…
Subsense has received $17 million in seed funding to accelerate the development of a nanoparticle-based brain-computer interface to help…
Researchers in the U.K. have successfully generated small antibodies, or nanobodies, that can target toxic aggregates of misfolded proteins, including…
Swedish-based Smartcella has entered an agreement with a research team from the Karolinska Institute for the exclusive rights to…
Get regular updates to your inbox.